Organogenesis Holdings Statistics
Total Valuation
ORGO has a market cap or net worth of $368.18 million. The enterprise value is $383.19 million.
Market Cap | 368.18M |
Enterprise Value | 383.19M |
Important Dates
The next confirmed earnings date is Thursday, May 9, 2024, after market close.
Earnings Date | May 9, 2024 |
Ex-Dividend Date | n/a |
Share Statistics
ORGO has 131.96 million shares outstanding. The number of shares has increased by 0.27% in one year.
Shares Outstanding | 131.96M |
Shares Change (YoY) | +0.27% |
Shares Change (QoQ) | -0.60% |
Owned by Insiders (%) | 33.32% |
Owned by Institutions (%) | 44.96% |
Float | 61.84M |
Valuation Ratios
The trailing PE ratio is 69.75 and the forward PE ratio is 12.32.
PE Ratio | 69.75 |
Forward PE | 12.32 |
PS Ratio | 0.85 |
Forward PS | 0.80 |
PB Ratio | 1.32 |
P/FCF Ratio | 56.18 |
PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 10.64, with an EV/FCF ratio of 58.48.
EV / Earnings | 77.49 |
EV / Sales | 0.88 |
EV / EBITDA | 10.64 |
EV / EBIT | 30.46 |
EV / FCF | 58.48 |
Financial Position
The company has a current ratio of 2.80, with a Debt / Equity ratio of 0.43.
Current Ratio | 2.80 |
Quick Ratio | 2.31 |
Debt / Equity | 0.43 |
Debt / EBITDA | 3.31 |
Debt / FCF | 18.21 |
Interest Coverage | 5.75 |
Financial Efficiency
Return on equity (ROE) is 1.80% and return on invested capital (ROIC) is 1.50%.
Return on Equity (ROE) | 1.80% |
Return on Assets (ROA) | 1.10% |
Return on Capital (ROIC) | 1.50% |
Revenue Per Employee | $502,483 |
Profits Per Employee | $5,737 |
Employee Count | 862 |
Asset Turnover | 0.95 |
Inventory Turnover | 4.02 |
Taxes
In the past 12 months, ORGO has paid $5.45 million in taxes.
Income Tax | 5.45M |
Effective Tax Rate | 52.42% |
Stock Price Statistics
The stock price has increased by +35.44% in the last 52 weeks. The beta is 1.57, so ORGO's price volatility has been higher than the market average.
Beta (1Y) | 1.57 |
52-Week Price Change | +35.44% |
50-Day Moving Average | 3.08 |
200-Day Moving Average | 3.10 |
Relative Strength Index (RSI) | 45.43 |
Average Volume (30 Days) | 733,832 |
Short Selling Information
The latest short interest is 7.23 million, so 5.48% of the outstanding shares have been sold short.
Short Interest | 7.23M |
Short Previous Month | 8.01M |
Short % of Shares Out | 5.48% |
Short % of Float | 11.69% |
Short Ratio (days to cover) | 9.31 |
Income Statement
In the last 12 months, ORGO had revenue of $433.14 million and earned $4.95 million in profits. Earnings per share was $0.04.
Revenue | 433.14M |
Gross Profit | 326.66M |
Operating Income | 12.53M |
Pretax Income | 10.39M |
Net Income | 4.95M |
EBITDA | 36.03M |
EBIT | 12.58M |
Earnings Per Share (EPS) | $0.04 |
Balance Sheet
The company has $104.34 million in cash and $119.35 million in debt, giving a net cash position of -$15.01 million or -$0.11 per share.
Cash & Cash Equivalents | 104.34M |
Total Debt | 119.35M |
Net Cash | -15.01M |
Net Cash Per Share | -$0.11 |
Equity / Book Value | 278.66M |
Book Value Per Share | 2.11 |
Working Capital | 144.54M |
Cash Flow
In the last 12 months, operating cash flow was $30.92 million and capital expenditures -$24.36 million, giving a free cash flow of $6.55 million.
Operating Cash Flow | 30.92M |
Capital Expenditures | -24.36M |
Free Cash Flow | 6.55M |
FCF Per Share | $0.05 |
Margins
Gross margin is 75.42%, with operating and profit margins of 2.89% and 1.14%.
Gross Margin | 75.42% |
Operating Margin | 2.89% |
Pretax Margin | 2.40% |
Profit Margin | 1.14% |
EBITDA Margin | 8.32% |
EBIT Margin | 2.90% |
FCF Margin | 1.51% |
Dividends & Yields
ORGO does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -0.27% |
Shareholder Yield | -0.27% |
Earnings Yield | 1.34% |
FCF Yield | 1.78% |
Analyst Forecast
The average price target for ORGO is $4.83, which is 73.12% higher than the current price. The consensus rating is "Buy".
Price Target | $4.83 |
Price Target Difference | 73.12% |
Analyst Consensus | Buy |
Analyst Count | 3 |
Revenue Growth Forecast (5Y) | n/a |
EPS Growth Forecast (5Y) | n/a |
Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |
Scores
ORGO has an Altman Z-Score of 2.5 and a Piotroski F-Score of 5. A Z-score under 3 suggests an increased risk of bankruptcy.
Altman Z-Score | 2.5 |
Piotroski F-Score | 5 |